Clinical trial

Feasibility Trial for a Right Ventricular Failure Platform Trial

NCT06570473

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-07-15

PhasePHASE2

Study timeline

Study start (actual)2025-07-15Date precision: day

Registry last updated2025-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Right Ventricular Dysfunctionunresolved

Right Heart Failureunresolved

Interventions

EmpagliflozinDRUG

Sponsors & collaborators

University of Albertalead sponsor

Canadian Heart Function Alliancecollaborator

Accelerating Clinical Trials Consortiumcollaborator

Ottawa Heart Institute Research Corporationcollaborator

Team PHenomenal Hopecollaborator

Mapped research locations

VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06570473 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.